The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on the Henry Ford Health System. [electronic resource]
- Managed care interface 2001
- 21-3 p. digital
Publication Type: Journal Article
1096-5645
Anti-Ulcer Agents--economics Decision Making, Organizational Delivery of Health Care, Integrated--economics Drug Costs Enzyme Inhibitors--economics Formularies as Topic Gastroesophageal Reflux--drug therapy Humans Institutional Management Teams Michigan Organizational Policy Proton Pump Inhibitors